• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载有贝达喹啉的聚合物胶束纳米粒用于治疗结核病的亚细胞定位和疗效研究:斑马鱼模型

Subcellular localization and therapeutic efficacy of polymeric micellar nanoparticles encapsulating bedaquiline for tuberculosis treatment in zebrafish.

机构信息

Department of Biosciences, University of Oslo, Blindernveien 31, 0371 Oslo, Norway.

Instituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, C/Mariano Esquillor s/n, 50018 Zaragoza, Spain.

出版信息

Biomater Sci. 2023 Mar 14;11(6):2103-2114. doi: 10.1039/d2bm01835g.

DOI:10.1039/d2bm01835g
PMID:36723226
Abstract

The combination drug regimens that have long been used to treat tuberculosis (TB), caused by , are fraught with problems such as frequent administration, long duration of treatment, and harsh adverse effects, leading to the emergence of multidrug resistance. Moreover, there is no effective preventive vaccine against TB infection. In this context, nanoparticles (NPs) have emerged as a potential alternative method for drug delivery. Encapsulating antibiotics in biodegradable NPs has been shown to provide effective therapy and reduced toxicity against in different mammalian models, when compared to conventional free drug administration. Here, we evaluate the localization, therapeutic efficacy and toxic effects of polymeric micellar NPs encapsulating a promising but highly hydrophobic and toxic antitubercular drug bedaquiline (BQ) in zebrafish embryos infected with Our study shows that the NP formulation of BQ improves survival and reduces bacterial burden in the infected embryos after treatment when compared to its free form. The intravenously injected BQ NPs have short circulation times due to their rapid and efficient uptake into the endothelial cells, as observed by correlative light and electron microscopy (CLEM).

摘要

长期以来,联合药物疗法一直被用于治疗结核分枝杆菌( )引起的结核病,但存在频繁给药、治疗时间长和严重不良反应等问题,导致出现了耐多药结核分枝杆菌。此外,目前还没有针对结核分枝杆菌感染的有效预防疫苗。在这种情况下,纳米颗粒(NPs)已成为一种有潜力的药物递送替代方法。与传统的游离药物给药相比,将抗生素封装在可生物降解的 NPs 中已被证明可在不同的哺乳动物模型中提供针对结核分枝杆菌的有效治疗并降低毒性。在这里,我们评估了在感染结核分枝杆菌的斑马鱼胚胎中,包封有前途但高度疏水和有毒的抗结核药物贝达喹啉(BQ)的聚合物胶束 NPs 的定位、治疗效果和毒性作用。我们的研究表明,与游离形式相比,BQ 的 NP 制剂在治疗后可提高感染胚胎的存活率并降低细菌负荷。静脉注射的 BQ NPs 由于其迅速而有效地被内皮细胞摄取,因此在相关的光镜和电子显微镜(CLEM)下观察到其循环时间很短。

相似文献

1
Subcellular localization and therapeutic efficacy of polymeric micellar nanoparticles encapsulating bedaquiline for tuberculosis treatment in zebrafish.载有贝达喹啉的聚合物胶束纳米粒用于治疗结核病的亚细胞定位和疗效研究:斑马鱼模型
Biomater Sci. 2023 Mar 14;11(6):2103-2114. doi: 10.1039/d2bm01835g.
2
Thioridazine in PLGA nanoparticles reduces toxicity and improves rifampicin therapy against mycobacterial infection in zebrafish.聚乳酸-羟基乙酸共聚物纳米粒包裹的硫利达嗪可降低毒性,并改善利福平对斑马鱼分枝杆菌感染的治疗效果。
Nanotoxicology. 2016 Aug;10(6):680-8. doi: 10.3109/17435390.2015.1107146. Epub 2015 Nov 17.
3
The zebrafish embryo as an in vivo model for screening nanoparticle-formulated lipophilic anti-tuberculosis compounds.斑马鱼胚胎作为一种体内筛选纳米颗粒包裹的亲脂性抗结核化合物的模型。
Dis Model Mech. 2022 Jan 1;15(1). doi: 10.1242/dmm.049147. Epub 2022 Jan 26.
4
Nanoparticles as drug delivery system against tuberculosis in zebrafish embryos: direct visualization and treatment.纳米颗粒作为斑马鱼胚胎中抗结核病的药物传递系统:直接可视化和治疗。
ACS Nano. 2014 Jul 22;8(7):7014-26. doi: 10.1021/nn5019126. Epub 2014 Jun 24.
5
Π-Π interactions stabilize PeptoMicelle-based formulations of Pretomanid derivatives leading to promising therapy against tuberculosis in zebrafish and mouse models.π-π相互作用稳定了基于肽胶束的前托马尼德衍生物制剂,从而在斑马鱼和小鼠模型中展现出对抗结核病的前景。
J Control Release. 2023 Feb;354:851-868. doi: 10.1016/j.jconrel.2023.01.037. Epub 2023 Feb 1.
6
Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis.将他莫昔芬重新用于结核病潜在的宿主导向治疗。
mBio. 2023 Feb 28;14(1):e0302422. doi: 10.1128/mbio.03024-22. Epub 2022 Dec 7.
7
Intracellular Activity of Poly (DL-Lactide-co-Glycolide) Nanoparticles Encapsulated with Prothionamide, Pyrazinamide, Levofloxacin, Linezolid, or Ethambutol on Multidrug-Resistant .用丙硫异烟胺、吡嗪酰胺、左氧氟沙星、利奈唑胺或乙胺丁醇包封的聚(DL-丙交酯-共-乙交酯)纳米颗粒对耐多药菌的细胞内活性
Curr Drug Deliv. 2023;20(3):306-316. doi: 10.2174/1567201819666220511120215.
8
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
9
Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs.人工智能支持的抛物线响应面平台确定了包含已批准药物的超快速近通用结核病药物治疗方案。
PLoS One. 2019 May 10;14(5):e0215607. doi: 10.1371/journal.pone.0215607. eCollection 2019.
10
Efficacy of Long-Acting Bedaquiline Regimens in a Mouse Model of Tuberculosis Preventive Therapy.长效贝达喹啉方案在结核病预防性治疗小鼠模型中的疗效
Am J Respir Crit Care Med. 2022 Mar 1;205(5):570-579. doi: 10.1164/rccm.202012-4541OC.

引用本文的文献

1
Recent advancements in drug development for pulmonary tuberculosis.肺结核药物研发的最新进展。
Arch Microbiol. 2025 Aug 30;207(10):245. doi: 10.1007/s00203-025-04415-y.
2
In vivo antimicrobial activity of engineered mesoporous silica nanoparticles targeting intracellular mycobacteria.靶向细胞内分枝杆菌的工程化介孔二氧化硅纳米颗粒的体内抗菌活性
Nat Commun. 2025 Aug 11;16(1):7388. doi: 10.1038/s41467-025-62623-y.
3
Expanding the field of view - a simple approach for interactive visualisation of electron microscopy data.扩展视野 - 一种用于电子显微镜数据交互式可视化的简单方法。
J Cell Sci. 2024 Oct 15;137(20). doi: 10.1242/jcs.262198. Epub 2024 Oct 23.
4
Breaking barriers: The potential of nanosystems in antituberculosis therapy.突破障碍:纳米系统在抗结核治疗中的潜力
Bioact Mater. 2024 May 17;39:106-134. doi: 10.1016/j.bioactmat.2024.05.013. eCollection 2024 Sep.
5
Mycobacterium tuberculosis β-lactamase variant reduces sensitivity to ampicillin/avibactam in a zebrafish-Mycobacterium marinum model of tuberculosis.结核分枝杆菌β-内酰胺酶变体降低了在斑马鱼-海分枝杆菌结核模型中氨苄西林/阿维巴坦的敏感性。
Sci Rep. 2023 Sep 16;13(1):15406. doi: 10.1038/s41598-023-42152-8.